X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse GSK Consumer with NESTLE SA - Switz. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK CONSUMER vs NESTLE (Switz.) - Comparison Results

GSK CONSUMER    Change

GSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More

NESTLE (Switz.)
   Change

Nestle SA headquartered in Switzerland, is the world's leading nutrition, health and wellness company. Its product portfolio consists of coffee, water, dairy, ice cream, infant nutrition, performance nutrition, healthcare nutrition, chocolate, frozen... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 GSK CONSUMER   NESTLE
EQUITY SHARE DATA
    GSK CONSUMER
Mar-18
NESTLE
Dec-14
GSK CONSUMER/
NESTLE
5-Yr Chart
Click to enlarge
High Rs6,7935,207-   
Low Rs4,9194,539-   
Sales per share (Unadj.) Rs1,026.32,059.7-  
Earnings per share (Unadj.) Rs166.5324.1-  
Cash flow per share (Unadj.) Rs181.8439.0-  
Dividends per share (Unadj.) Rs75.00156.29-  
Dividend yield (eoy) %1.33.2 39.9%  
Book value per share (Unadj.) Rs828.61,572.4-  
Shares outstanding (eoy) m42.063,168.40-   
Bonus/Rights/Conversions -OI-  
Price / Sales ratio x5.72.4 241.2%   
Avg P/E ratio x35.215.0 234.0%  
P/CF ratio (eoy) x32.211.1 290.2%  
Price / Book Value ratio x7.13.1 228.0%  
Dividend payout %45.148.2 93.4%   
Avg Mkt Cap Rs m246,28415,440,703 1.6%   
No. of employees `0004.0339.0 1.2%   
Total wages/salary Rs m5,2771,145,591 0.5%   
Avg. sales/employee Rs Th10,837.319,251.0 56.3%   
Avg. wages/employee Rs Th1,325.03,379.3 39.2%   
Avg. net profit/employee Rs Th1,757.73,029.4 58.0%   
INCOME DATA
Net Sales Rs m43,1656,526,090 0.7%  
Other income Rs m2,57428,345 9.1%   
Total revenues Rs m45,7396,554,435 0.7%   
Gross profit Rs m8,8341,688,550 0.5%  
Depreciation Rs m644364,080 0.2%   
Interest Rs m2054,843 0.0%   
Profit before tax Rs m10,7441,297,972 0.8%   
Minority Interest Rs m0-31,826 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,743239,192 1.6%   
Profit after tax Rs m7,0011,026,954 0.7%  
Gross profit margin %20.525.9 79.1%  
Effective tax rate %34.818.4 189.0%   
Net profit margin %16.215.7 103.1%  
BALANCE SHEET DATA
Current assets Rs m45,6202,412,589 1.9%   
Current liabilities Rs m17,4262,336,861 0.7%   
Net working cap to sales %65.31.2 5,628.8%  
Current ratio x2.61.0 253.6%  
Inventory Days Days3536 95.0%  
Debtors Days Days2453 44.1%  
Net fixed assets Rs m5,1382,019,028 0.3%   
Share capital Rs m42122,875 1.8%   
"Free" reserves Rs m34,4310-   
Net worth Rs m34,8514,982,035 0.7%   
Long term debt Rs m0880,612 0.0%   
Total assets Rs m54,1272,376,288 2.3%  
Interest coverage x530.224.7 2,149.6%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x0.82.7 29.0%   
Return on assets %13.045.5 28.5%  
Return on equity %20.120.6 97.5%  
Return on capital %30.922.5 137.1%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m2,8280-   
CASH FLOW
From Operations Rs m7,2301,044,288 0.7%  
From Investments Rs m-4,465-218,235 2.0%  
From Financial Activity Rs m-3,634-755,652 0.5%  
Net Cashflow Rs m-86870,401 -1.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for NESTLE (Switz.) is Switzerland Francs. All data has been converted at 71.04 Rs / CHF

Compare GSK CONSUMER With: TIGER BRANDS (S. Africa)  COCA COLA (US)  AVI LTD. (S. Africa)  

Compare GSK CONSUMER With: NESTLE  KRBL LIMITED  GOODRICKE  UNITED SPIRITS  RUCHI SOYA INDUSTRIES  



Today's Market

Recapitalisation Package for PSBs: The Pros & Cons(Podcast)

Corporate governance issues with certain companies, uncertainty surrounding national elections and global issues like trade wars, Brexit, have taken a toll on the Indian markets.

Related Views On News

GSK CONSUMER Announces Quarterly Results (3QFY19); Net Profit Up 35.1% (Quarterly Result Update)

Feb 18, 2019 | Updated on Feb 18, 2019

For the quarter ended December 2018, GSK CONSUMER has posted a net profit of Rs 2 bn (up 35.1% YoY). Sales on the other hand came in at Rs 11 bn (up 7.9% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

GSK CONSUMER Announces Quarterly Results (2QFY19); Net Profit Up 43.2% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, GSK CONSUMER has posted a net profit of Rs 3 bn (up 43.2% YoY). Sales on the other hand came in at Rs 13 bn (up 14.0% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

GSK Consumer: On the Recovery Path (Quarterly Results Update - Detailed)

Jun 20, 2017

While GSK consumer reported muted revenue growth, volumes are seen to be recovering.

Prataap Snacks Ltd. (IPO)

Sep 21, 2017

Is the Prataap Snacks IPO worth your attention?

Apex frozen food Ltd. (IPO)

Aug 21, 2017

Should you subscribe to the IPO of Apex Frozen Foods Ltd?

More Views on News

Most Popular

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Don't Be Afraid of the Market; Buy Stocks Like This One(The 5 Minute Wrapup)

Feb 14, 2019

During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

The 4-Point Plan to Accelerate India to a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Feb 12, 2019

Two questions I have been eagerly waiting to ask you ever since Budget 2019 was announced.

The Train to 'Small-Cap-Profits Land' is Back on the Station!(Profit Hunter)

Feb 15, 2019

Why its great news that prices for small caps over the last few days have been falling like there's no tomorrow.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

GSK CONSUMER SHARE PRICE


Feb 22, 2019 (Close)

TRACK GSK CONSUMER

  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK CONSUMER 5-YR ANALYSIS

COMPARE GSK CONSUMER WITH

MARKET STATS